
South Jefferson community seeks answers about rare pediatric cancer cases
A South Jefferson community is raising concerns about several reported Ewing sarcoma cases and asking health officials to investigate.
By the ClickNNY North Country Desk
Residents in the South Jefferson Central School District are seeking answers after several children and young adults in the community were diagnosed with Ewing sarcoma, a rare cancer that affects bones. The reported cases include students Hunter Stoffel, Ashton Marcum and Tucker, along with other cases in recent years. Naomi Gushlaw, 8, died in 2015, and Jordan Hancock, 29, recently died after a recurrence, according to initial reports.
The New York State Department of Health said it is working with Jefferson County to monitor the concerns. Community members, including Lisa Wilson and county district representative Chris Boulio, are calling for more information about whether environmental factors could be involved. Medical experts said Ewing sarcoma has no known cause and is not known to be passed through families. The American Cancer Society estimates about 250 children in the United States are diagnosed with the disease each year.
Reported by ClickNNY and reviewed by an editor before publication.
More from ClickNNY
Guides and features from across the North Country.

ClickNNY Guide · Fort Drum
Next Move NY: Watertown guide to jobs and training for veterans
Next Move NY helps transitioning soldiers, military spouses and veterans connect with civilian jobs, training and education in the North Country.

ClickNNY Special Report · Hidden NNY
Area 51 Was Once Called "Watertown." Inside the North Country's UFO Files
A viral "jellyfish" sighting near an Alaska air base has everyone looking up. Here's what soldiers, troopers and families have reported over Fort Drum and the St. Lawrence for 70 years, the two cases nobody explained, and the real story behind the secret base that shares Watertown's name.

ClickNNY Featured · Health
Lighter for a Season, or Healthier for a Lifetime?
A new FDA eye warning, a steep monthly price and research on what happens after the shots stop are sharpening one question for North Country families using GLP-1 drugs: are the changes going to last?